Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Importation of Organic Chemicals into the U.S.
January 23, 2012
By: Robert E.
The Harmonized Tariff Schedule of the United States (HTSUS)1 classifies goods based on a variety of attributes, such as name, use or material in its makeup. The schedule consists of 99 chapters and a variety of appendices, and is used to assign the 10-digit numbers necessary to import compounds into the U.S.2 Organic chemicals are described in chapters 28-30 but mainly in chapter 29. HTSUS classification depends primarily on the structure of a compound, but is also affected by other characteristics such as its source or use. Major changes the international Harmonized System (HS) goods nomenclature, and the resultant changes in the HTSUS expected in early 2012, make a review of this topic especially timely.
HTSUS Number
In the U.S. the Harmonized Tariff Schedule classification is a 10-digit number as illustrated in Figure 1. The first six digits are internationally harmonized and consist of a chapter, heading, and subheading; the last four digits are U.S. specific, consisting of U.S. tariff rates and statistical reporting.
Key Organizations
International
The World Customs Organization (WCO)3 is the intergovernmental organization responsible for maintaining the international Harmonized System (HS) goods nomenclature for the 206 participating nations.
U.S.
Types of Classification
Methods of
Classification
1. Manual Lookup: Internal personnel with a technical background (often chemists and/or former customs agents) can classify compounds by manually looking them up in the HTSUS. Alternatively, some brokers and consultants will provide classifications, via manual lookup, for chemicals as part of a larger HTSUS classification service. Some formal training is usually required to perform this function for chemical classification.
For organizations importing only a small number of compounds this can be a reasonably efficient method. In addition, with a static list of chemical imports it is relatively simple to set up a database — basically a lookup table of identifier versus HTSUS classification.
The advantages of manual lookup are the flexibility to consider all aspects of the assignment, including source and use, and not base the classification strictly on structure. The main problems with manual lookup are
2. Automated Lookup: Several companies have written their own in-house automated HTS classification applications. Accelrys’ Pipeline Pilot is the most popular software for these applications, while Chemcart has also been used. There is also at least one commercially available automated HTSUS application available.
Advantages of automated lookup are
Resources
Updates
Evaluation and Summary
Any organization that imports chemicals into the U.S., including big pharma, biotechs, chemical companies and CROs/CMOs, must classify compounds in the HTSUS system in order to get their compounds through U.S. Customs and pay the appropriate tariffs. Failure to meet a customs requirement can result in monetary fines (which can reach $100,000 per violation), as well as penalties ranging from seizing the merchandise to serving actual jail time.16 In practice, the federal government regards compliance with U.S. import requirements as a shared responsibility between U.S. Customs and industry.
Organizations with modest numbers of compounds or a static list of compounds to import can use manual lookup with a reasonable expectancy that they will be compliant, and if not, that minor corrections will not result in fines.
Larger numbers of compounds can be very problematic. Imports consisting of several hundred to tens of thousands of new compounds can be a challenge. It is impractical to expect U.S. Customs to produce binding rulings for more than a handful of compounds, and a 30-day turnaround (although, in practice rulings are often faster than that) does not lend itself to today’s fast pace for international trade. Likewise, manual lookup is also impractical for large numbers of samples unless they are relatively homogenous, say, small variations on a structural theme.
The only practical way to deal with large numbers of diverse compounds is to use automated methods, which are based solely on the structure of the molecule being classified. Although disregarding non-structural information can be seen as a disadvantage, in practice manual lookup (like automated lookup) is usually based primarily, if not solely, on structure.
Coupling disclaimers with automated methods allows selected human interaction to modify classifications when pertinent, non-structural information is available. For example, Ribavirin (Figure 3) could be classified as 2934.99.9000 based on chemical classification, which provides for “Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds: Other: Other: Other: Other: Other” and a disclaimer for this classification would state “Unless ‘Drugs, then HTS – 2934.99.4700”. An end-user who is aware that Ribavirin is a “Drug” (or can look up the binding ruling) would know that the disclaimer applies. If they are only aware of the structure it is unlikely they would make this distinction.
A variety of different methods are being utilized to perform the function of classifying chemicals in the HTSUS system for import into the U.S. The complexity of the schedule virtually guarantees that no organization will be 100% compliant. Likewise, U.S. Cus-toms has neither the tools nor the resources to comprehensively monitor all chemicals coming into the U.S. for HTSUS compliance. Being able to document due diligence is probably the best an organization can do to deal with this complex task and minimize risk of non-compliance.
References
Robert E. Schwartz was a scientist at Merck & Co. for 26 years and is one of the recipients of the ACS 2006 Heroes of Chemistry awards for the discovery of Cancidas. He is presently the owner of MyIslandBeach LLC (www.myislandbeach.net/) and can be contacted at schwart@optonline.net.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !